Target intelligence / Profile preview

Major prion protein (PrP)

Target
PrP
Molecular classification
Other, Cell surface glycoprotein (GPI-anchored protein), Disease-associated protein (prion family)
01

Overview

The major prion protein (PrP), encoded by the PRNP gene, is a highly conserved glycoprotein primarily expressed in the nervous system and tethered to the cell surface via a glycosylphosphatidylinositol (GPI) anchor[1][2][4][7]. While its precise physiological function is unclear, PrP is implicated in neuroprotection, copper metabolism, and the formation and maintenance of neuronal synapses[3]. The normal cellular form, PrP^C^, can misfold into a protease-resistant conformer, PrP^Sc^, which aggregates and drives transmissible spongiform encephalopathies (prion diseases) such as Creutzfeldt–Jakob disease, kuru, and scrapie[1][3]. PrP is not an enzyme or classic receptor, but its pathological conformer is a unique causative agent for neurodegenerative disease and a high-profile drug target for rare but lethal disorders. No approved drugs with established efficacy currently exist against prion diseases, although PrP remains intensively studied for potential therapeutics and diagnostics[1][3].

Other names
PrPPrP^C^CD230Cluster of differentiation 230Prion proteinPrion protein cellular formPrP^Sc^ (for pathological form)PRIPALTPRP
02

Mechanism of action

Direct binding and stabilization of normal PrP conformation (investigational); Prevention of PrP^C^ to PrP^Sc^ conversion (research, experimental); Inhibition of prion aggregation (research)

03

Biological functions

NeuroprotectionCopper ion transportSynapse formation and maintenanceCell signalingCell adhesion
04

Disease associations

Neurodegenerative diseasePrion disease (e.g., Creutzfeldt–Jakob disease, kuru, fatal familial insomnia, Gerstmann–Sträussler–Scheinker syndrome)Huntington’s disease-like syndromesVariant Creutzfeldt–Jakob disease (vCJD)Other transmissible spongiform encephalopathies (TSEs)
05

Safety considerations

No current effective or approved drug therapyIrreversible, uniformly fatal neurodegeneration when misfolded prion forms are presentRisk of iatrogenic transmission through medical procedures with contaminated instruments due to resilience of PrP^Sc^
06

Interacting drugs

Pentosan polysulfate (investigational, studied for prion disease)

2 more in the full profile.

07

Biomarkers

Detection of misfolded PrP^Sc^ in cerebrospinal fluid or tissues (diagnostic biomarker for prion diseases)RT-QuIC assay (real-time quaking-induced conversion, to detect PrP^Sc^ aggregation)Elevated 14-3-3 protein as clinical screening marker (not specific)

Beyond the preview

Go deeper on Major prion protein (PrP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major prion protein (PrP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call